DEA schedule

Is Gralise a controlled substance?

Gralise contains gabapentin. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

No. Gralise (gabapentin) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and gabapentin is not on the DEA controlled substances list.

Run it in Rivvi

Which 2027 plans near you dropped or restricted Gralise?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Gralise
SourceWhat it lists
FDA NDC directory5 prescription listings from 1 labelers, none with a DEA schedule
DEA controlled substances listgabapentin is not on the list

Gralise NDC listings

NDC listings for Gralise
NDCProductFormStrengthLabelerDEA schedule
52427-803Gralisetablet, film coated300 mg/1Almatica Pharma LLCNone
52427-804Gralisetablet, film coated450 mg/1Almatica Pharma LLCNone
52427-806Gralisetablet, film coated600 mg/1Almatica Pharma LLCNone
52427-850Gralisetablet, film coated750 mg/1Almatica Pharma LLCNone
52427-890Gralisetablet, film coated900 mg/1Almatica Pharma LLCNone

Questions

Is Gralise a controlled substance?

No. Gralise (gabapentin) is not a federally controlled substance. None of its FDA NDC listings carries a DEA schedule, and gabapentin is not on the DEA controlled substances list.

Is Gralise a narcotic?

No. Gralise (gabapentin) is not on the DEA controlled substances list, so the DEA does not classify it as a narcotic.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.

More on Gralise

Try it on your own data today.

Free to start. Most teams are using it the same day.